SENEA Stock Analysis: Seneca Foods | NASDAQ
Packaged Foods | NASDAQ, USA | Market Cap: 1.185m USD | 12M Return: 72% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 26.2M
EPS Trend: 30.3%
Rev. Trend: 78.0%
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Seneca Foods Corporation is a U.S.-based packaged food company that produces canned, frozen, and jarred fruits and vegetables, along with snack chips and related products. It operates in the Consumer Staples sector (Packaged Foods & Meats sub-industry), serving demand that tends to be relatively stable across economic cycles.
The companys business model combines private-label manufacturing with a portfolio of owned and licensed national and regional brands, including Aunt Nellies, CherryMan, Green Giant, Green Valley, Libbys, READ, and Seneca. In addition to its branded retail products, Seneca offers contract packing services for canned and frozen vegetables to other food companies, a common arrangement in the packaged foods industry that helps smooth capacity utilization.
Seneca sells through a diverse customer base that includes supermarkets, mass merchandisers, limited assortment stores, club stores, and dollar stores, as well as specialty retailers, food service distributors, restaurant chains, industrial buyers, other food packagers, and federal, state, and local government feeding programs. It reaches approximately 55 export markets and operates ancillary businesses supplying cans, ends, and seeds, as well as aircraft operations. The company was incorporated in 1949 and is headquartered in Fairport, New York.
- Private label and dollar store channel volumes expand revenue
- Green Giant brand licensing royalty income supports operating margins
- Agricultural input and steel can cost inflation pressures gross margins
| Net Income: 114.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA -10.80 > 1.0 |
| NWC/Revenue: 37.67% < 20% (prev 34.27%; Δ 3.40% < -1%) |
| CFO/TA 0.18 > 3% & CFO 224.5m > Net Income 114.7m |
| Net Debt (250.5m) to EBITDA (192.4m): 1.30 < 3 |
| Current Ratio: 5.06 > 1.5 & < 3 |
| Outstanding Shares: last quarter (6.83m) vs 12m ago -1.82% < -2% |
| Gross Margin: 13.93% > 18% (prev 9.51%; Δ 4.42% > 0.5%) |
| Asset Turnover: 136.6% > 50% (prev 133.6%; Δ 3.00% > 0%) |
| Interest Coverage Ratio: 8.18 > 6 (EBIT TTM 148.4m / Interest Expense TTM 18.1m) |
| A: 0.50 (Total Current Assets 779.1m - Total Current Liabilities 153.9m) / Total Assets 1.25b |
| B: 0.69 (Retained Earnings 860.4m / Total Assets 1.25b) |
| C: 0.12 (EBIT TTM 148.4m / Avg Total Assets 1.21b) |
| D: 1.54 (Book Value of Equity 756.2m / Total Liabilities 491.5m) |
| Altman-Z'' = 7.97 = AAA |
| DSRI: 1.10 (Receivables 112.0m/97.0m, Revenue 1.66b/1.58b) |
| GMI: 0.68 (GM 9.51% / 13.93%) |
| AQI: 1.36 (AQ_t 0.09 / AQ_t-1 0.07) |
| SGI: 1.05 (Revenue 1.66b / 1.58b) |
| TATA: -0.09 (NI 114.7m - CFO 224.5m) / TA 1.25b) |
| Beneish M = -2.99 (Cap -4..+1) = A |
As of July 13, 2026, the stock is trading at USD 176.69 with a total of 63,763 shares traded. Over the past week, the price has changed by -3.96%, over one month by +0.75%, over three months by +7.51% and over the past year by +72.03%.
Current recommended Stop Loss: 161.30 (which is 8.7% or 1.9 ATR below the current price).
Seneca Foods has no consensus analysts rating.
| Analysts Target Price | 202 | 14.3% |
P/E Trailing = 10.5313
P/E Forward = 39.3701
P/S = 0.7139
P/B = 1.5931
P/EG = 0.8314
Revenue TTM = 1.66b USD
EBIT TTM = 148.4m USD
EBITDA TTM = 192.4m USD
Long Term Debt = 239.1m USD (from longTermDebt, last quarter)
Short Term Debt = 25.3m USD (from shortTermDebt, last quarter)
Debt = 300.4m USD (from shortLongTermDebtTotal, last quarter) + Leases 18.1m
Net Debt = 250.5m USD (calculated: Debt 300.4m - CCE 49.9m)
Enterprise Value = 1.44b USD (1.18b + Debt 300.4m - CCE 49.9m)
Interest Coverage Ratio = 8.18 (Ebit TTM 148.4m / Interest Expense TTM 18.1m)
EV/FCF = 7.97x (Enterprise Value 1.44b / FCF TTM 180.2m)
FCF Yield = 12.55% (FCF TTM 180.2m / Enterprise Value 1.44b)
FCF Margin = 10.86% (FCF TTM 180.2m / Revenue TTM 1.66b)
Net Margin = 6.91% (Net Income TTM 114.7m / Revenue TTM 1.66b)
Gross Margin = 13.93% ((Revenue TTM 1.66b - Cost of Revenue TTM 1.43b) / Revenue TTM)
Gross Margin QoQ = 11.19% (prev 16.42%)
Tobins Q-Ratio = 1.15 (Enterprise Value 1.44b / Total Assets 1.25b)
Interest Expense / Debt = 6.04% (Interest Expense 18.1m / Debt 300.4m)
Taxrate = 23.09% (34.4m / 149.1m)
NOPAT = 114.1m (EBIT 148.4m * (1 - 23.09%))
Current Ratio = 5.06 (Total Current Assets 779.1m / Total Current Liabilities 153.9m)
Debt / Equity = 0.40 (Debt 300.4m / totalStockholderEquity, last quarter 756.2m)
Debt / EBITDA = 1.30 (Net Debt 250.5m / EBITDA 192.4m)
Debt / FCF = 1.39 (Net Debt 250.5m / FCF TTM 180.2m)
Total Stockholder Equity = 696.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 9.44% (Net Income 114.7m / Total Assets 1.25b)
RoE = 16.46% (Net Income TTM 114.7m / Total Stockholder Equity 696.8m)
RoCE = 15.86% (EBIT 148.4m / Capital Employed (Equity 696.8m + L.T.Debt 239.1m))
RoIC = 10.67% (NOPAT 114.1m / Invested Capital 1.07b)
WACC = 6.15% (E(1.18b)/V(1.49b) * Re(6.53%) + D(300.4m)/V(1.49b) * Rd(6.04%) * (1-Tc(0.23)))
Discount Rate = 6.53% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.88 | Cagr: -2.35%
[DCF] Terminal Value 73.10% ; FCFF base≈227.4m ; Y1≈199.4m ; Y5≈161.1m
[DCF] Fair Price = 447.4 (EV 2.59b - Net Debt 250.5m = Equity 2.34b / Shares 5.22m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 30.32 | EPS CAGR: 10.72% | SUE: N/A | # QB: 0
Revenue Correlation: 78.03 | Revenue CAGR: 3.69% | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=2.92 | Chg30d=N/A | Revisions=+0% | Analysts=1
EPS next Quarter (2026-09-30): EPS=4.12 | Chg30d=N/A | Revisions=+0% | Analysts=1
EPS current Year (2027-03-31): EPS=14.84 | Chg30d=N/A | Revisions=+0% | GrowthEPS=-10.5% | GrowthRev=+10.0%
EPS next Year (2028-03-31): EPS=13.93 | Chg30d=N/A | Revisions=+0% | GrowthEPS=-6.1% | GrowthRev=+2.3%